Historical record - last NADAC publication: 6/22/2022
Strength
11.25; 69 mg/1; mg/1
Manufacturer
Vivus LLCNDC
62541020330
Classification
Brand
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
6/22/2022
Active Ingredients
PHENTERMINE HYDROCHLORIDE; TOPIRAMATEApproval Type
New Drug (NDA)
FDA Application
NDA022580On Market Since
9/17/2012
Pharmacological Classes
Price Statistics
The NADAC for QSYMIA 11.25 MG-69 MG CAPSULE has been published 450 times since May 21, 2014, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.3732 per EA |
|---|---|
| All-time high | $6.5249 (Aug 10, 2016) |
| All-time low | $6.3732 (Jun 22, 2022) |
| Median price | $6.3851 |
| Average price | $6.4150 |
| Largest weekly change | +2.0% (Oct 21, 2015) |
| Weeks tracked | 450 |
| Tracking since | May 21, 2014 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 52% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of QSYMIA 11.25 MG-69 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for QSYMIA 11.25 MG-69 MG CAPSULE, manufactured by Vivus LLC, is $6.3732 per EA (NDC 62541020330), effective Dec 28, 2022.
How has the price of QSYMIA 11.25 MG-69 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for QSYMIA 11.25 MG-69 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 450 weekly CMS publications since May 21, 2014.
What are the highest and lowest recorded NADAC prices for QSYMIA 11.25 MG-69 MG CAPSULE?
Since May 21, 2014, the NADAC for QSYMIA 11.25 MG-69 MG CAPSULE has ranged from a low of $6.3732 (Jun 22, 2022) to a high of $6.5249 (Aug 10, 2016), with a median of $6.3851 per EA.
Are there cheaper alternatives to QSYMIA 11.25 MG-69 MG CAPSULE?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, PHENTERMINE-TOPIRAMATE ER 11.25-69 MG CAPSULE, is $3.0277 per EA — about 52% below QSYMIA 11.25 MG-69 MG CAPSULE.
Who manufactures QSYMIA 11.25 MG-69 MG CAPSULE?
QSYMIA 11.25 MG-69 MG CAPSULE (NDC 62541020330) is labeled by Vivus LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification